This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignee: Marinus Pharmaceuticals. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chestnut Hill, MA (US) (2022)
- Radnor, PA (US) (2021 - 2023)
Company Filing History:
Years Active: 2021-2025
Title: Lorianne Masuoka: Pioneering Innovations in Epilepsy Treatment
Introduction: Lorianne Masuoka is an esteemed inventor based in Chestnut Hill, MA, known for her significant contributions to the field of neurology. With a total of four patents to her name, she has been at the forefront of developing advanced treatments for critical health conditions, particularly focusing on epilepsy.
Latest Patents: Among her notable inventions, Lorianne's latest patents involve the use of ganaxolone for the treatment of status epilepticus. This innovative method relates to administering an intravenous bolus of ganaxolone, accompanied by a continuous intravenous infusion of a neurosteroid. This approach is designed to provide suppression of status epilepticus (SE) and ensure continued management of the condition.
Career Highlights: Lorianne Masuoka's work is primarily associated with Marinus Pharmaceuticals, where she has collaborated with a talented team to refine and implement her groundbreaking ideas. Her dedication and expertise have led to significant advancements in pharmaceuticals, especially those targeted toward neurological disorders.
Collaborations: Working alongside esteemed colleagues such as Alex Aimetti and David Czekai, Lorianne has leveraged collaborative efforts to enhance the development of her patents. This teamwork has been integral to the success of her projects, as they bring together diverse perspectives and expertise needed for innovative medical solutions.
Conclusion: Lorianne Masuoka stands out as a leading inventor in the medical field, particularly with her focus on epilepsy treatment. Her patents are indicative of her commitment to improving patient outcomes and advancing medical science. As she continues her work at Marinus Pharmaceuticals, her contributions will undoubtedly pave the way for future innovations in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile